Venlafaxine-related galactorrhea in an adolescent female : A case report
Copyright © 2022 Elsevier Inc. All rights reserved..
Hyperprolactinemia with galactorrhea is a well-documented adverse effect of some psychotropic medications. While advanced practice psychiatric nurses are likely familiar with hyperprolactinemia with galactorrhea as an adverse effect of antipsychotics, they may be less familiar with hyperprolactinemia with galactorrhea associated with antidepressants, an adverse effect that is far less common. Advanced practice psychiatric nurses must be able to identify hyperprolactinemia and galactorrhea in patients and must be able to evaluate and manage antidepressant-related hyperprolactinemia with galactorrhea. Thus, this case report describes hyperprolactinemia with galactorrhea in a teenage female prescribed venlafaxine for the treatment of major depressive disorder and posttraumatic stress disorder. To our knowledge, this is the first case report that describes galactorrhea related to a reuptake inhibitor (SNRI) in an adolescent.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Archives of psychiatric nursing - 40(2022) vom: 01. Okt., Seite 106-108 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kameg, Brayden N [VerfasserIn] |
---|
Links: |
---|
Themen: |
7D7RX5A8MO |
---|
Anmerkungen: |
Date Completed 08.09.2022 Date Revised 23.09.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.apnu.2022.06.001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345814096 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345814096 | ||
003 | DE-627 | ||
005 | 20231226025929.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.apnu.2022.06.001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1152.xml |
035 | |a (DE-627)NLM345814096 | ||
035 | |a (NLM)36064232 | ||
035 | |a (PII)S0883-9417(22)00056-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kameg, Brayden N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Venlafaxine-related galactorrhea in an adolescent female |b A case report |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2022 | ||
500 | |a Date Revised 23.09.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a Hyperprolactinemia with galactorrhea is a well-documented adverse effect of some psychotropic medications. While advanced practice psychiatric nurses are likely familiar with hyperprolactinemia with galactorrhea as an adverse effect of antipsychotics, they may be less familiar with hyperprolactinemia with galactorrhea associated with antidepressants, an adverse effect that is far less common. Advanced practice psychiatric nurses must be able to identify hyperprolactinemia and galactorrhea in patients and must be able to evaluate and manage antidepressant-related hyperprolactinemia with galactorrhea. Thus, this case report describes hyperprolactinemia with galactorrhea in a teenage female prescribed venlafaxine for the treatment of major depressive disorder and posttraumatic stress disorder. To our knowledge, this is the first case report that describes galactorrhea related to a reuptake inhibitor (SNRI) in an adolescent | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Adolescents | |
650 | 4 | |a SNRIs | |
650 | 7 | |a Antidepressive Agents |2 NLM | |
650 | 7 | |a Venlafaxine Hydrochloride |2 NLM | |
650 | 7 | |a 7D7RX5A8MO |2 NLM | |
700 | 1 | |a Wilson, Rose |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Archives of psychiatric nursing |d 1996 |g 40(2022) vom: 01. Okt., Seite 106-108 |w (DE-627)NLM01279189X |x 1532-8228 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2022 |g day:01 |g month:10 |g pages:106-108 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.apnu.2022.06.001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2022 |b 01 |c 10 |h 106-108 |